DalsnaFinance › IPOs › MiNK Therapeutics › IPO
MiNK Therapeutics, Inc. completed its initial public offering on NASDAQ on October 15, 2021, pricing at $12.00 a share.
| Ticker | INKT |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 15, 2021 |
| Offering price | $12.00 |
| Shares offered | 3,333,334 |
| Total raised | $40M |
MiNK Therapeutics, Inc. sold 3,333,334 shares at $12.00 each on NASDAQ. Multiplied out, that is $40 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $40 million total recorded for the deal.
MiNK Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for MiNK Therapeutics, Inc.. This page is general information, not investment advice.